In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. COVID- 19 Tests are carried out to screen for and detect infections caused by the emerging pathogen, the SARS-CoV-2- coronavirus, which was first identified in China in early 2020. GlobalData uses proprietary data and analytics to provide a comprehensive report on the covid-19 tests devices market, including market shares of different players within Canada. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the covid-19 tests market in Canada was F. Hoffmann-La Roche followed by Hologic, bioMerieux, Abbott Laboratories, Danaher, Becton Dickinson and Co, Qiagen, DiaSorin, Thermo Fisher Scientific, Revvity, BGI Genomics, QuidelOrtho and Altona Diagnostic.
COVID-19 Tests include COVID-19 Laboratory Tests – Nucleic Acid Amplification Tests (NAATs), COVID-19 Singleplex Nucleic Acid Amplification Tests (NAATs) and, COVID-19 Multiplex Nucleic Acid Amplification Tests (NAATs).
The value of the covid-19 tests devices market within Canada was expected to be over $100m in 2023.
For the latest complete market share analysis of covid-19 tests device market in Canada, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.